Targeted Agents in Cervical Cancer: Beyond Bevacizumab
Sign Up to like & getrecommendations! Published in 2018 at "Current Oncology Reports"
DOI: 10.1007/s11912-018-0680-3
Abstract: Cervical cancer constitutes a leading cause of morbidity and cancer deaths in women throughout the world. Approximately two thirds of the patients are diagnosed with locally advanced cervical cancer, showing disappointing survival rates despite correct… read more here.
Keywords: bevacizumab; targeted agents; cervical cancer; agents cervical ... See more keywords